Supporting fundraising for Maverix Oncology

10 Sep 2025 | by Andrii Koniukh

Maverix Oncology - Supporting fundraising

BACK TO BLOG

MaveriX Oncology is exploiting new insights into cancer and immune cell metabolism to advance a new generation of Conditionally Activated Small Molecule TherapeuticsTM designed to specifically co-target cancer and the tumor immune microenvironment.

Challenge

Challenge

Approach

Approach

Results

Results

The Goal

To translate complex scientific concepts into compelling, easy-to-understand visuals that could be used both for fundraising and for enhancing the website.

The deliverables included:

- a high-quality 3D animation to illustrate the scientific approach;

-  visually appealing assets to strengthen online presence.

MaveriX Oncology 02

 

Project in numbers

8 weeks: Duration from the idea to the final delivery

2 meetings: Communication with the client is essential for us. To listen to them and provide the best result

2 rounds: Two feedback rounds on the production stage

Sign up for our newsletter